Histological transformation of indolent (follicular) lymphoma

Annals of Oncology

Volumn 7, Issue 8, 1996, Pages 849-853

  Ottensmeier, C ^a   Mead, G ^a  

^a ROYAL SOUTH HANTS HOSPITAL   (United Kingdom)

Author keywords

Follicular lymphoma; Prognosis; Transformation; Treatment

Indexed keywords

BLEOMYCIN; CARMUSTINE; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; MELPHALAN; METHOTREXATE; PREDNISOLONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINCRISTINE;

ADULT; ARTICLE; CASE REPORT; FEMALE; FOLLICULAR LYMPHOMA; HISTOLOGY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALIGNANT TRANSFORMATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029906913     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.annonc.a010765     Document Type: Article

References (31)

1. Horning SJ. Natural history of and therapy for the indolent non-Hodgkins's lymphomas. Semin Oncol 1993; 20: 75-88.
2. Ersbøll J, Shultz HB, Pedersen-Bjergaard J et al. Follicular low grade non-Hodgkin's lymphoma: Long-term outcome with or without tumor progression. Eur J Haematol 1989; 42: 155-63.
3. Simon R, Durrleman S, Hoppe RT et al. The Non-Hodgkin Lymphoma Pathologic Classification Project. Long-term follow-up of 1153 patients with non-Hodgkin lymphomas. Ann Int Med 1988; 109: 939-45.
4. Rappaport H, Winter WJ, Hicks EB. Follicular lymphoma. A re-evaluation of its position in the scheme of malignant lymphoma, based on a survey of 253 cases. Cancer 1956; 9: 792-821.
5. Yuen AR, Kamel OW, Halpern J et al. Long-term survival after histologic transformation of low-grade follicular lymphoma. J Clin Oncol 1995; 13: 1726-33.
6. Sweetenham JW, Mead GM, Whitehouse JMA. Intensive weekly combination chemotherapy for patients with intermediate-grade and high-grade non-Hodgkin's lymphoma. J Clin Oncol 1991; 9: 2202-9.
7. Gribben JG, Goldstone AH, Taghipour G et al. Effectiveness of high-dose combination chemotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphomas who are still responsive to conventional-dose therapy. J Clin Oncol 1989; 7: 1621-9.
8. The Non-Hodgkin's Lymphoma Pathological Classification Project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphoma. Summary and description of a working formulation for clinical usage. Cancer 1982; 49: 2112-35.
9. Harris NL, Jaffe ES, Stein H et al. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-92.
10. Sham RL, Phatak P, Carignan J et al. Progression of follicular large cell lymphoma to Burkitt's lymphoma. Cancer 1989; 63: 700-2.
11. Sander CA, Yano T, Clark HM et al. p53 mutation is associated with progression in follicular lymphomas. Blood 1993; 82: 1994-2004.
12. Symmans WF, Katz RL, Ordonez NG et al. Transformation of follicular lymphoma. Expression of p53 and bcl-2 oncoprotein, apoptosis and cell proliferation. Acta Cytol 1995; 39: 673-82.
13. Moormeier JA, Williams SF, Golomb HM. The staging of non-Hodgkin's lymphomas. Semin Oncol 1990; 17: 43-50.
14. Portlock CS. Management of the low-grade non-Hodgkin's lymphomas. Semin Oncol 1990; 17: 51-9.
15. Romaguera JE, McLaughlin P, North L et al. Multivariate analysis of prognostic factors in stage IV follicular low-grade lymphoma: A risk model. J Clin Oncol 1991; 9: 762-9.
16. Cameron DA, Leonard RCF, Mao JH et al. Identification of prognostic groups in follicular lymphoma. Leuk Lymph 1993; 10: 89-99.
17. Bastion Y, Berger F, Bryon P-A et al. Follicular lymphomas: Assessment of prognostic factors in 127 patients followed for 10 years. Ann Oncol 1991; 2 (Suppl. 2): 123-9.
18. Lopez-Guillermo A, Montserrat E, Bosch F et al. Applicability of the International Index for aggressive lymphomas to patients with low-grade lymphoma. J Clin Oncol 1994; 12: 1343-8.
19. Bastion Y, Coiffier B. Is the International Prognostic Index for aggressive lymphoma patients useful for follicular lymphoma patients? J Clin Oncol 1994; 12: 1340-2 (Editorial).
20. Leonard RCF, Hayward RL, Prescott RJ et al. The identification of discrete prognostic groups in low grade non-Hodgkin's lymphoma. Ann Oncol 1991; 2: 655-62.
21. Mac Manus MP, Hoppe RT. Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University. J Clin Oncol 1996; 14: 1282-90.
22. Young RC, Longo DL, Glatstein E et al. The treatment of indolent lymphomas: Watchful waiting v aggressive combined modality treatment. Semin Hematol 1988; 25 (Suppl): 11-6.
23. Dana BW, Dahlberg S, Nathwani BN et al. Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmunotherapy. J Clin Oncol 1993; 11: 644-51.
24. Horning SJ. Treatment approaches to the low-grade lymphomas. Blood 1994; 83: 881-4.
25. Hochster HS, Kim KM, Green MD et al. Activity of fludarabine in previously treated non-Hodgkin's low-grade lymphoma: Results of an Eastern Cooperative Oncology Group study. J Clin Oncol 1992; 10: 28-32.
26. McLaughlin P, Grillo-Lopez AJ, Czuczmann M et al. Preliminary report on a phase III pivotal trial of the anti-CD20 antibody (MAB) IDEC-C2B8 in patients with relapsed low-grade of follicular lymphoma. Proc Am Soc Clin Oncol 1996; 15: 417 (Abstr 1281).
27. Kaminski R, Zazadny K, Francis I et al. Iodine B1 anti-B radioimmunotherapy for B-cell lymphoma. J Clin Oncol 1996; 14: 1974-84.
28. Garvin AJ, Simon RM, Osborne CK et al. An autopsy study of histologic progression in non-Hodgkin's lymphomas. 192 cases from the National Cancer Institute. Cancer 1983; 52: 393-8.
29. Hubbard SM, Chabner BA, De Vita VT et al. Histologic progression in non-Hodgkin's lymphoma. Blood 1982; 59: 258-64.
30. Schouten HC, Bierman PJ, Vaughan WP et al. Autologous bone marrow transplantation in follicular non-Hodgkin's lymphoma before and after histologic transformation. Blood 1989; 74: 2579-84.
31. Freedman AS, Ritz J, Neuberg D et al. Autologous bone marrow transplantation in 69 patients with a history of low-grade B-cell non-Hodgkin's lymphoma. Blood 1991; 77: 2524-9.